Skip to main content

Table 1 Demographic data of the patients

From: Clinical pharmacist-led assessment and management of anticholinergic burden and fall risk in geriatric patients

Variables

Control (n = 301)

Intervention (n = 300)

Total (n = 601)

p

Gender, n (%)

 Female

190 (63.1)

199 (66.3)

389 (64.7)

0.410

 Male

111 (36.9)

101 (36.7)

212 (35.3)

Age (years), mean (SD)

75.77 (7.44)

74.57 (7.01)

75.10 (7.25)

0.373

 65–74

147 (48.8)

158 (52.7)

305 (50.7)

0.193

 75–84

113 (37.5)

115 (38.3)

228 (37.9)

 ≥85

41 (13.6)

27 (9.0)

68 (11.3)

Weight (kg), mean (SD)

75.91 (15.23)

76.74 (14.94)

76.37 (15.06)

0.594

Height (cm), mean (SD)

162.16 (8.52)

160.56 (9.20)

161.27 (8.93)

0.034*

BMI (kg/m2), mean (SD)

30.33 (6.42)

29.89 (5.91)

30.09 (6.97)

0.205

Marital status, n (%)

 Married

184 (61.1)

185 (61.7)

369 (61.4)

0.012*

 Divorced

112 (37.2)

97 (32.3)

209 (34.8)

 Widowed

5 (1.7)

18 (6.0)

23 (3.8)

Number of children, median (range)

3 (0–9)

4 (0–9)

3 (0–9)

0.881

Smoking, n (%)

69 (22.9)

71 (23.7)

140 (23.3)

0.829

Alcohol, n (%)

5 (1.7)

9 (3.0)

14 (2.3)

0.414

Allergy, n (%)

5 (1.7)

10 (3.3)

15 (2.5)

0.293

Fall within the last year, n (%)

77 (25.6)

94 (31.3)

171 (28.5)

0.118

Influenza vaccination, n (%)

40 (13.3)

48 (16.0)

88 (14.6)

0.347

Pneumococcal vaccination, n (%)

71 (23.6)

73 (24.3)

144 (24.0)

0.831

Forgetfulness, n (%)

167 (60.5)

177 (59.0)

344 (59.7)

0.713

Progressive forgetfulness, n (%)

108 (39.3)

106 (35.3)

214 (37.2)

0.329

Diagnosis, n (%)

 Hypertension

233 (77.4)

246 (82.0)

479 (79.7)

0.162

 Diabetes mellitus

151 (50.2)

148 (49.3)

299 (49.8)

0.838

 Coronary artery disease

122 (40.5)

111 (37.0)

233 (38.8)

0.374

 Hypothyroidism

43 (14.3)

35 (11.7)

78 (13.0)

0.339

 Atrial fibrillation

48 (15.9)

28 (9.3)

76 (12.6)

0.015*

 Osteoporosis

42 (14.0)

33 (11.0)

75 (12.5)

0.273

 Asthma

42 (14.0)

33 (11.0)

75 (12.5)

0.273

 Congestive heart failure

36 (12.0)

34 (11.3)

70 (11.6)

0.811

 Chronic kidney disease

33 (11.0)

27 (9.0)

60 (10.0)

0.422

 COPD

30 (10.0)

21 (7.0)

51 (8.5)

0.247

 Acute renal failure

19 (6.3)

10 (3.3)

29 (4.8)

0.130

 Liver failure

3 (1.0)

2 (0.7)

5 (0.8)

1.000

CCI, mean (SD)

6.01 (2.90)

5.50 (2.32)

5.75 (2.61)

0.559

ADLs (n = 547), mean (SD)

5.02 (1.68)

5.21 (1.43)

5.12 (1.55)

0.938

IADLs (n = 543), mean (SD)

5.92 (2.88)

6.17 (2.74)

6.05 (2.81)

0.891

MNA-SF (n = 428), mean (SD)

11.59 (3.06)

11.41 (3.52)

11.49 (3.31)

0.996

GDS (n = 454), mean (SD)

4.79 (4.33)

4.18 (3.96)

4.47 (4.15)

0.633

MMSE (n = 508), mean (SD)

25.99 (5.78)

25.43 (6.36)

25.71 (6.08)

0.379

CDT (n = 443), mean (SD)

3.85 (2.39)

3.71 (2.50)

3.78 (2.45)

0.968

  1. BMI: Body mass index, COPD: Chronic obstructive pulmonary disease, CCI: Charlson Comorbidity Index, ADLs: Activities of Daily Living, IADLs: Instrumental Activities of Daily Living, MNA-SF: Mini Nutritional Assessment-Short Form, GDS: Geriatric Depression Scale, MMSE: Mini Mental State Examination, CDT: Clock Drawing Test